Paras Healthcare Ltd. logo

Paras Healthcare Ltd.

PARASHLTH

Equity

BSE,NSE

Min. Investment :

₹6,60,000.00

IPO Details

Bidding Dates

21 Oct 26-23 Oct 26

Price Range ₹

660 -693

Total Equity

₹ 837.37Cr

Lot Size

21

Exchange Status

BSE,NSE

Subscription Rate

Non-Institutional Investor

2.00×

Qualified Institutional Buyers

3.09×

Employees

0.00×

Retail Investors

2.00×

Total subscription Rate

2.23×

IPO Timeline

About Company

Paras Health is the fifth-largest healthcare provider in North India, Bihar, and Jharkhand based on bed capacity, operating 2,135 beds across eight hospitals as of March 31, 2024. The company specializes in tertiary care services, focusing on Tier 2 and Tier 3 cities with key clinical areas such as cardiac sciences, oncology, and orthopedics. With 18 years of experience, Paras Health follows an asset-light expansion strategy to grow in underserved regions. It aims to increase its bed capacity to 2,935 by 2029 with new hospitals planned in Gurugram and Ludhiana. Additionally, the company is investing in digital healthcare solutions to enhance patient care.

Year Founded

21-12-1987

Promotor Details

Saurabh Sood

Offer to Public

1,20,83,331.00 Cr

Promoter Holdings Details

ParticularPre-IPOPost-IPO

Percentage

75.32

0

Share Capital

73519240

0

Project Details

Prepayment or scheduled re-payment of a portion of certain outstanding borrowings availed by our Com -3209cr

Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar) -541cr

Objectives

Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by our CompanyInvestment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPLGeneral corporate purposes

Highlights

Positioned as a leading healthcare provider in underserved markets of North India with a first-mover advantage.

Asset-light approach enhances operational efficiency and drives patient accessibility.

Strong ability to attract and retain top medical talent, ensuring high-quality patient care.

Presence across multiple specialties, payor mixes, and geographic locations reduces reliance on any single segment.

Robust infrastructure, advanced technology, and a experienced, doctor-led management team provide a solid foundation for growth.

Challenges

A history of losses raises concerns about the company's financial stability and future profitability.

Dependence on attracting and retaining skilled healthcare professionals creates vulnerability to staffing challenges.

Regulatory changes and pharmaceutical pricing uncertainties could negatively impact financial performance.

Reliance on in-patient revenue and occupancy rates exposes the company to fluctuations in demand and pricing.

Non-exclusive doctor arrangements and potential non-compliance with regulations pose operational and financial risks.

Financials

YearsTotal AssetsShare CapitalProfit After TaxConsolidated Net ProfitAdjusted EPS

2022

9,635.28

36.76

-579.83

-579.83

-5.9403

2026

20,711.41

100.99

-148.08

-148.08

-2.0141

2023

12,931.01

36.76

-579.83

-579.83

-5.9403

2024

14,776.58

97.61

386.50

386.50

5.2571

2025

18,104.51

97.61

-253.52

-258.85

-3.5208